These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3800191)

  • 1. Propranolol, epinephrine, and accelerated hypertension during hemodialysis.
    Whelan TV
    Ann Intern Med; 1987 Feb; 106(2):327. PubMed ID: 3800191
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol-epinephrine interaction: a potential disaster.
    Foster CA; Aston SJ
    Plast Reconstr Surg; 1983 Jul; 72(1):74-8. PubMed ID: 6867180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe epinephrine-propranolol interaction.
    Gandy W
    Ann Emerg Med; 1989 Jan; 18(1):98-9. PubMed ID: 2910169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic adrenergic crisis.
    Corcoy R
    Lancet; 2002 May; 359(9320):1850. PubMed ID: 12044393
    [No Abstract]   [Full Text] [Related]  

  • 5. The propanolol-epinephrine interaction revisited: a serious and potentially catastrophic adverse drug interaction in facial plastic surgery.
    Centeno RF; Yu YL
    Plast Reconstr Surg; 2003 Feb; 111(2):944-5. PubMed ID: 12560730
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of epinephrine and propranolol.
    Spencer PS; Klein LE
    J Am Acad Dermatol; 1986 Jun; 14(6):1093-4. PubMed ID: 3722489
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol-epinephrine interaction.
    Greenwald AE
    J Dermatol Surg Oncol; 1983 Sep; 9(9):713. PubMed ID: 6886184
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible interaction of epinephrine with propranolol.
    Catalano PM
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):839. PubMed ID: 6725674
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenergic blocking agents and dental vasoconstrictors.
    Hersh EV; Giannakopoulos H
    Dent Clin North Am; 2010 Oct; 54(4):687-96. PubMed ID: 20831932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol-associated hypoglycemia in patients on maintenance hemodialysis.
    Zarate A; Gelfand M; Novello A; Knepshield J; Preuss HG
    Int J Artif Organs; 1981 May; 4(3):130-4. PubMed ID: 7275342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine interactions with beta-blockers.
    Wynn RL
    Gen Dent; 1994; 42(1):16, 18. PubMed ID: 7911769
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycemia in chronic hemodialysis patients: association with propranolol use.
    Grajower MM; Walter L; Albin J
    Nephron; 1980; 26(3):126-9. PubMed ID: 7412967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Propranolol.
    Kram J; Bourne HR; Melmon KL; Maibach H
    Ann Intern Med; 1974 Feb; 80(2):282. PubMed ID: 4811811
    [No Abstract]   [Full Text] [Related]  

  • 14. Clonidine and propranolol paradoxical hypertension.
    Warren SE; Ebert E; Swerdlin AH; Steinberg SM; Stone R
    Arch Intern Med; 1979 Feb; 139(2):253. PubMed ID: 434988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood glucose levels in patients on hemodialysis during propranolol (Inderal) treatment].
    Jensen HA; Laursen PA; Moller BB
    Ugeskr Laeger; 1976 Nov; 138(47):2956-7. PubMed ID: 982647
    [No Abstract]   [Full Text] [Related]  

  • 16. Dihydroergotamine interaction with propranolol.
    Gandy W
    Ann Emerg Med; 1990 Feb; 19(2):221. PubMed ID: 2301806
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertensive crisis caused by hypoglycemia and propranolol.
    Mann SJ; Krakoff LR
    Arch Intern Med; 1984 Dec; 144(12):2427-8. PubMed ID: 6391408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental drug interactions with the greatest potential for serious adverse effects.
    Wynn RL
    Gen Dent; 1994; 42(2):116-7. PubMed ID: 8056271
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of epinephrine when given to patients taking propranolol (inderal).
    Merck S
    J Emerg Nurs; 1995 Feb; 21(1):27-32. PubMed ID: 7776572
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
    Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.